Abstract
Bone invasion is a common characteristic of oral squamous cell carcinoma (OSCC), with adverse affects on patient functionality and survival. Recent studies suggest that it is osteoclasts, rather than malignant keratinocytes themselves, which play the major role in facilitating the entry of the tumour into bone, and its progression within bone. Osteoclasts respond to a variety of local signalling pathways, initiated by products of the malignant epithelial cells. In the present review, we firstly introduce the clinical patterns of bone invasion, and then summarise these signalling pathways and their diverse roles in sequential phases of bone invasion. We also review current researches regarding the incidence and mechanisms of distant metastases to bone, and explain briefly the concept of epithelial-mesenchymal transition, which may generate cancer stem cells and initiate the bone invasion. Finally, we discuss more briefly approaches to the diagnosis and management of OSCC patients with bone invasion. With all these studies and some recent discoveries in our own laboratory, an enhanced understanding of bone invasion will be achieved, which should indicate potential molecular targets for future biotherapies.
Similar content being viewed by others
References
Warnakulasuriya, S. (2009). Global epidemiology of oral and oropharyngeal cancer. Oral Oncology, 45(4–5), 309–316.
Johnson, N. W., Jayasekara, P., & Amarasinghe, A. A. H. K. (2011). Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontology 2000, 57(1), 19–37.
Johnson, N. W., Warnakulasuriya, S., Gupta, P. C., Dimba, E., Chindia, M., Otoh, E. C., et al. (2011). Global inequalities in incidence and outcomes for oral cancer: causes and solutions. Advances in Dental Research, 23(2), 237–246.
Chen, Y. L., Kuo, S. W., Fang, K. H., & Hao, S. P. (2011). Prognostic impact of marginal mandibulectomy in the presence of superficial bone invasion and the nononcologic outcome. Head & Neck, 33(5), 708–713.
Lubek, J., El-Hakim, M., Salama, A. R., Liu, X., & Ord, R. A. (2011). Gingival carcinoma: retrospective analysis of 72 patients and indications for elective neck dissection. British Journal of Oral and Maxillofacial Surgery, 49(3), 182–185.
Hoffmannová, J., Foltán, R., Vlk, M., Sipos, M., Horká, E., Pavlíková, G., et al. (2010). Hemimandibulectomy and therapeutic neck dissection with radiotherapy in the treatment of oral squamous cell carcinoma involving mandible: a critical review of treatment protocol in the years 1994–2004. International Journal of Oral and Maxillofacial Surgery, 39(6), 561–567.
Pandey, M., Rao, L. P., Das, S. R., Mathews, A., Chacko, E. M., & Naik, B. R. (2007). Patterns of mandibular invasion in oral squamous cell carcinoma of the mandibular region. World Journal of Surgical Oncology, 30, 5–12.
Brown, J. S., Lowe, D., Kalavrezos, N., D’Souza, J., Magennis, P., & Woolgar, J. (2002). Patterns of invasion and routes of tumor entry into the mandible by oral squamous cell carcinoma. Head & Neck, 24(4), 370–383.
Shaw, R. J., Brown, J. S., Woolgar, J. A., Lowe, D., Rogers, S. N., & Vaughan, E. D. (2004). The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma. Head & Neck, 26(10), 861–869.
Brown, J. S., & Browne, R. M. (1995). Factors influencing the patterns of invasion of the mandible by oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery, 24(6), 417–426.
Ito, M., Izumi, N., Cheng, J., Sakai, H., Shingaki, S., Nakajima, T., et al. (2003). Jaw bone remodeling at the invasion front of gingival squamous cell carcinomas. Journal of Oral Pathology & Medicine, 32(1), 10–17.
Goda, T., Shimo, T., Yoshihama, Y., Hassan, N. M., Ibaragi, S., Kurio, N., et al. (2010). Bone destruction by invading oral squamous carcinoma cells mediated by the transforming growth factor-beta signalling pathway. Anticancer Research, 30(7), 2615–2623.
Ebrahimi, A., Murali, R., Gao, K., Elliott, M. S., & Clark, J. R. (2011). The prognostic and staging implications of bone invasion in oral squamous cell carcinoma. Cancer, 117(19), 4460–4467.
Wysluch, A., Stricker, I., Hölzle, F., Wolff, K. D., & Maurer, P. (2010). Intraoperative evaluation of bony margins with frozen-section analysis and trephine drill extraction technique: a preliminary study. Head & Neck, 32(11), 1473–1478.
Kayamori, K., Sakamoto, K., Nakashima, T., Takayanagi, H., Morita, K., Omura, K., et al. (2010). Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells. American Journal of Pathology, 176(2), 968–980.
Martin, C. K., Werbeck, J. L., Thudi, N. K., Lanigan, L. G., Wolfe, T. D., Toribio, R. E., et al. (2010). Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma. Cancer Research, 70(21), 8607–8616.
Yavropoulou, M. P., & Yovos, J. G. (2008). Osteoclastogenesis–current knowledge and future perspectives. Journal of Musculoskeletal and Neuronal Interactions, 8(3), 204–216.
Hadjidakis, D. J., & Androulakis, I. I. (2006). Bone remodeling. Annals of the New York Academy of Sciences, 1092, 385–396.
Raggatt, L. J., & Partridge, N. C. (2010). Cellular and molecular mechanisms of bone remodeling. Journal of Biological Chemistry, 285(33), 25103–25108.
Georges, S., Ruiz, Velasco, C., Trichet, V., Fortun, Y., Heymann, D., et al. (2009). Proteases and bone remodelling. Cytokine & Growth Factor Reviews, 20(1), 29–41.
Woodward, J. K., Holen, I., Coleman, R. E., & Buttle, D. J. (2007). The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer. Bone, 41(6), 912–927.
Krane, S. M., & Inada, M. (2008). Matrix metalloproteinases and bone. Bone, 43(1), 7–18.
Kessenbrock, K., Plaks, V., & Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 141(1), 52–67.
Erdem, N. F., Carlson, E. R., Gerard, D. A., & Ichiki, A. T. (2007). Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. Journal of Oral and Maxillofacial Surgery, 65(9), 1725–1733.
Chuang, H. C., Su, C. Y., Huang, H. Y., Huang, C. C., Chien, C. Y., Du, Y. Y., et al. (2008). Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma. Modern Pathology, 21(12), 1444–1450.
Thiolloy, S., Halpern, J., Holt, G. E., Schwartz, H. S., Mundy, G. R., Matrisian, L. M., et al. (2009). Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis. Cancer Research, 69(16), 6747–6755.
Lynch, C. C., Hikosaka, A., Acuff, H. B., Martin, M. D., Kawai, N., Singh, R. K., et al. (2005). MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell, 7(5), 485–496.
Goto, T., Yamaza, T., & Tanaka, T. (2003). Cathepsins in the osteoclast. Journal of Electron Microscopy, 52(6), 551–558.
Kawamata, H., Nakashiro, K., Uchida, D., Harada, K., Yoshida, H., & Sato, M. (1997). Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines. International Journal of Cancer, 70(1), 120–127.
Henson, B., Li, F., Coatney, D. D., Carey, T. E., Mitra, R. S., Kirkwood, K. L., et al. (2007). An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma. Journal of Oral Pathology & Medicine, 36(6), 363–370.
Kawasaki, G., Kato, Y., & Mizuno, A. (2002). Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 93(4), 446–454.
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003). Osteoclast differentiation and activation. Nature, 423(6937), 337–342.
Datta, N. S., & Abou-Samra, A. B. (2009). PTH and PTHrP signaling in osteoblasts. Cellular Signalling, 21(8), 1245–1254.
Dougall, W. C., & Chaisson, M. (2006). The RANK/RANKL/OPG triad in cancer-induced bone diseases. Cancer and Metastasis Reviews, 25(4), 541–549.
Cochran, D. L. (2008). Inflammation and bone loss in periodontal disease. Journal of Periodontology, 79(8 Suppl), 1569–1576.
Ishikuro, M., Sakamoto, K., Kayamori, K., Akashi, T., Kanda, H., Izumo, T., et al. (2008). Significance of the fibrous stroma in bone invasion by human gingival squamous cell carcinomas. Bone, 43(3), 621–627.
Tada, T., Jimi, E., Okamoto, M., Ozeki, S., & Okabe, K. (2005). Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts. International Journal of Cancer, 116(2), 253–262.
Nakashima, T., & Takayanagi, H. (2008). The dynamic interplay between osteoclasts and the immune system. Archives of Biochemistry and Biophysics, 473(2), 166–171.
Bar-Shavit, Z. (2007). The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. Journal of Cellular Biochemistry, 102(5), 1130–1139.
Dewhirst, F. E., Stashenko, P. P., Mole, J. E., & Tsurumachi, T. (1985). Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta. Journal of Immunology, 135(4), 2562–2568.
Walsh, M. C., Kim, N., Kadono, Y., Rho, J., Lee, S. Y., Lorenzo, J., et al. (2006). Osteoimmunology: interplay between the immune system and bone metabolism. Annual Review of Immunology, 24, 33–63.
Okamoto, M., Hiura, K., Ohe, G., Ohba, Y., Terai, K., Oshikawa, T., et al. (2000). Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo. Cancer, 89(9), 1966–1975.
Shibahara, T., Nomura, T., Cui, N. H., & Noma, H. (2005). A study of osteoclast-related cytokines in mandibular invasion by squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery, 34(7), 789–793.
Van, Cann, E. M., de Slootweg, P. J., Wilde, P. C., Otte-Höller, I., Koole, R., et al. (2009). The prediction of mandibular invasion by squamous cell carcinomas with the expression of osteoclast-related cytokines in biopsy specimens. International Journal of Oral and Maxillofacial Surgery, 38(3), 279–284.
Tsuchimochi, M., Kameta, A., Sue, M., & Katagiri, M. (2005). Immunohistochemical localization of parathyroid hormone-related protein (PTHrP) and serum PTHrP in normocalcemic patients with oral squamous cell carcinoma. Odontology, 93(1), 61–71.
Deyama, Y., Tei, K., Yoshimura, Y., Izumiyama, Y., Takeyama, S., Hatta, M., et al. (2008). Oral squamous cell carcinomas stimulate osteoclast differentiation. Oncology Reports, 20(3), 663–668.
Yamada, T., Tsuda, M., Ohba, Y., Kawaguchi, H., Totsuka, Y., & Shindoh, M. (2008). PTHrP promotes malignancy of human oral cancer cell downstream of the EGFR signaling. Biochemical and Biophysical Research Communications, 368(3), 575–581.
Takayama, Y., Mori, T., Nomura, T., Shibahara, T., & Sakamoto, M. (2010). Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma. International Journal of Oncology, 36(6), 1387–1394.
Gronthos, S., & Zannettino, A. C. (2007). The role of the chemokine CXCL12 in osteoclastogenesis. Trends in Endocrinology and Metabolism, 18(3), 108–113.
Bonfil, R. D., Chinni, S., Fridman, R., Kim, H. R., & Cher, M. L. (2007). Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis. Urologic Oncology, 25(5), 407–411.
Tang, C. H., Chuang, J. Y., Fong, Y. C., Maa, M. C., Way, T. D., & Hung, C. H. (2008). Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kappaB pathways and promotes osteoclastogenesis in human oral cancer cells. Carcinogenesis, 29(8), 1483–1492.
Pandruvada, S. N., Yuvaraj, S., Liu, X., Sundaram, K., Shanmugarajan, S., Ries, W. L., et al. (2010). Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice. International Journal of Cancer, 126(10), 2319–2329.
Matsuo, K., & Irie, N. (2008). Osteoclast-osteoblast communication. Archives of Biochemistry and Biophysics, 473(2), 201–209.
Huang, S. M., Li, J., & Harari, P. M. (2002). Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade. Molecular Cancer Therapeutics, 1(7), 507–514.
Prime, S. S., Eveson, J. W., Stone, A. M., Huntley, S. P., Davies, M., Paterson, I. C., et al. (2004). Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-beta 1. The Journal of Pathology, 203(4), 927–932.
Shimo, T., Kubota, S., Goda, T., Yoshihama, Y., Kurio, N., Nishida, T., et al. (2008). Clinical significance and pathogenic function of connective tissue growth factor (CTGF/CCN2) in osteolytic mandibular squamous cell carcinoma. Anticancer Research, 28(4C), 2343–2348.
Van der Pluijm, G. (2011). Epithelial plasticity, cancer stem cells and bone metastasis formation. Bone, 48(1), 37–43.
Polyak, K., & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Reviews. Cancer, 9(4), 265–273.
Sterling, J. A., Edwards, J. R., Martin, T. J., & Mundy, G. R. (2011). Advances in the biology of bone metastasis: how the skeleton affects tumor behavior. Bone, 48(1), 6–15.
Chaffer, C. L., & Weinberg, R. A. (2011). A perspective on cancer cell metastasis. Science, 331(6024), 1559–1564.
Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704–715.
Davies, M., Prime, S. S., Stone, A. M., Huntley, S. P., Eveson, J. W., & Paterson, I. C. (2000). Endogenous TGF-beta1 inhibits the growth and metastatic dissemination of rat oral carcinoma cell lines but enhances local bone resorption. Journal of Oral Pathology & Medicine, 29(5), 232–240.
Qiao, B., Johnson, N. W., & Gao, J. (2010). Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and −9 expressions. International Journal of Oncology, 37(3), 663–668.
Zhau, H. E., Odero-Marah, V., Lue, H. W., Nomura, T., Wang, R., Chu, G., et al. (2008). Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model. Clinical & Experimental Metastasis, 25(6), 601–610.
Odero-Marah, V. A., Wang, R., Chu, G., Zayzafoon, M., Xu, J., Shi, C., et al. (2008). Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Research, 18(8), 858–870.
He, H., Yang, X., Davidson, A. J., Wu, D., Marshall, F. F., Chung, L. W., et al. (2010). Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis. Prostate, 70(5), 518–528.
Thompson, E. W., & Williams, E. D. (2008). EMT and MET in carcinoma–clinical observations, regulatory pathways and new models. Clinical & Experimental Metastasis, 25(6), 591–592.
Onder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., & Weinberg, R. A. (2008). Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Research, 68(10), 3645–3654.
Lo, J. F., Yu, C. C., Chiou, S. H., Huang, C. Y., Jan, C. I., Lin, S. C., et al. (2011). The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Research, 71(5), 1912–1923.
Sethi, S., Macoska, J., Chen, W., & Sarkar, F. H. (2010). Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. American Journal of Translational Resreach, 3(1), 90–99.
Lo, W. L., Yu, C. C., Chiou, G. Y., Chen, Y. W., Huang, P. I., Chien, C. S., et al. (2011). MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. The Journal of Pathology, 223(4), 482–495.
Pentenero, M., Cistaro, A., Brusa, M., Ferraris, M. M., Pezzuto, C., Carnino, R., et al. (2008). Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma. Head & Neck, 30(11), 1488–1496.
Vidiri, A., Guerrisi, A., Pellini, R., Manciocco, V., Covello, R., Mattioni, O., et al. (2010). Multi-detector row computed tomography (MDCT) and magnetic resonance imaging (MRI) in the evaluation of the mandibular invasion by squamous cell carcinomas (SCC) of the oral cavity. Correlation with pathological data. Journal of Experimental & Clinical Cancer Research, 17, 29–73.
Abd El-Hafez, Y. G., Chen, C. C., Ng, S. H., Lin, C. Y., Wang, H. M., Chan, S. C., et al. (2011). Comparison of PET/CT and MRI for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity. Oral Oncology, 47(4), 288–295.
Van, Cann, E. M., Koole, R., Oyen, W. J., de Rooy, J. W., de Wilde, P. C., et al. (2008). Assessment of mandibular invasion of squamous cell carcinoma by various modes of imaging: constructing a diagnostic algorithm. International Journal of Oral and Maxillofacial Surgery, 37(6), 535–541.
Ayad, T., Guertin, L., Soulières, D., Belair, M., Temam, S., & Nguyen-Tân, P. F. (2009). Controversies in the management of retromolar trigone carcinoma. Head & Neck, 31(3), 398–405.
Guerra, M. F., Campo, F. J., Gías, L. N., & Pérez, J. S. (2003). Rim versus sagittal mandibulectomy for the treatment of squamous cell carcinoma: two types of mandibular preservation. Head & Neck, 25(12), 982–989.
Scully, C., & Bagan, J. (2009). Oral squamous cell carcinoma overview. Oral Oncology, 45(4–5), 301–308.
Do, L., Syed, N., Puthawala, A., Azawi, S., Williams, R., & Vora, N. (2010). Prognostic significance of bone or cartilage invasion of locally advanced head and neck cancers. American Journal of Clinical Oncology, 33(6), 591–594.
Zhao, L., Guo, Q. L., You, Q. D., Wu, Z. Q., & Gu, H. Y. (2004). Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biological and Pharmaceutical Bulletin, 27(7), 998–1003.
Kasibhatla, S., Jessen, K. A., Maliartchouk, S., Wang, J. Y., English, N. M., Drewe, J., et al. (2005). A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proceedings of the National Academic of Science of the USA, 102(34), 12095–12100.
Oh, H. M., Kwon, B. M., Baek, N. I., Kim, S. H., Lee, J. H., Eun, J. S., et al. (2006). Inhibitory activity of 6-O-angeloylprenolin from Centipeda minima on farnesyl protein transferase. Archives of Pharmacal Research, 29(1), 64–66.
Taylor, R. S., & Towers, G. H. (1998). Antibacterial constituents of the Nepalese medicinal herb, Centipeda minima. Phytochemistry, 47(4), 631–634.
Xu, X., Liu, Y., Wang, L., He, J., Zhang, H., Chen, X., et al. (2009). Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl-2 and enhancing caspase-3 activity in human malignant melanoma A375 cells. International Journal of Dermatology, 48(2), 186–192.
Yan, F., Wang, M., Chen, H., Su, J., Wang, X., Wang, F., et al. (2011). Gambogenic acid mediated apoptosis through the mitochondrial oxidative stress and inactivation of Akt signaling pathway in human nasopharyngeal carcinoma CNE-1 cells. European Journal of Pharmacology, 652(1–3), 23–32.
Ding, L. F., Liu, Y., Liang, H. X., Liu, D. P., Zhou, G. B., & Cheng, Y. X. (2009). Two new terpene glucosides and antitumour agents from Centipeda minima. Journal of Asian Natural Products Research, 11(8), 732–736.
Changlong, L., Hezhen, W., Yongping, H., Yanfang, Y., Yanwen, L., & Jianwen, L. (2008). 6-O-Angeloylenolin induces apoptosis through a mitochondrial/caspase and NF-kappaB pathway in human leukemia HL60 cells. Biomedicine and Pharmacotherapy, 62(6), 401–409.
Liu, Y., Chen, X. Q., Liang, H. X., Zhang, F. X., Zhang, B., Jin, J., et al. (2011). Small compound 6-O-Angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myeloma. PLoS One, 6(7), e21930.
Ziober, B. L., Mauk, M. G., Falls, E. M., Chen, Z., Ziober, A. F., & Bau, H. H. (2008). Lab-on-a-chip for oral cancer screening and diagnosis. Head & Neck, 30(1), 111–121.
Santini, D., Galluzzo, S., Zoccoli, A., Pantano, F., Fratto, M. E., Vincenzi, B., et al. (2010). New molecular targets in bone metastases. Cancer Treatment Reviews, 36(Suppl 3), S6–S10.
Lee, R. J., Saylor, P. J., & Smith, M. R. (2011). Treatment and prevention of bone complications from prostate cancer. Bone, 48(1), 88–95.
Castellano, D., Sepulveda, J. M., García-Escobar, I., Rodriguez-Antolín, A., Sundlöv, A., & Cortes-Funes, H. (2011). The role of RANK-ligand inhibition in cancer: the story of denosumab. The Oncologist, 16(2), 136–145.
Body, J. J., Greipp, P., Coleman, R. E., Facon, T., Geurs, F., Fermand, J. P., et al. (2003). A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Cancer, 97(3 Suppl), 887–892.
Shin, M., Matsuo, K., Tada, T., Fukushima, H., Furuta, H., Ozeki, S., et al. (2011). The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Carcinogenesis (in press)
Acknowledgements
We thank Professors Glenn Francis and Jane Dahlstrom for supplying tissue sections from oral cancer patients with bone invasion. This study was supported by funds from China Scholarship Council, Griffith University International Postgraduate Research Scholarship and Australian Dental Research Foundation.
Conflict of interest
All authors declare to have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Quan, J., Johnson, N.W., Zhou, G. et al. Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms. Cancer Metastasis Rev 31, 209–219 (2012). https://doi.org/10.1007/s10555-011-9335-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10555-011-9335-7